
QIAGEN Gets U.S. Approval for Second QIAstat-Dx Mini GI Panel
QIAGEN Gets U.S. Approval for Second QIAstat-Dx Mini GI Panel QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has approved the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, enhancing…












